In Sweden, the number of people who smoke has decreased very sharply but the number of lung cancer cases in the population is not decreasing as much as expected. In fact, lung…
ICMR Set To Bring In Evidence Based Guidelines To Conduct Meta-Analyses
The Indian Council of Medical Research (ICMR) is all set to launch a systematic review and meta-analyses to help in decision making for management of lung cancer to guide clinical practice and…
World’s First Lung Cancer Vaccine is Being Developed by UK Researchers
Lung cancer is the deadliest form of cancers all around the world including Britain. Every year, around 50,000 cases and 35,000 deaths of patients with lung cancer are reported in Britain alone….
New Deep Learning Tool To Predict Brain Metastasis In Lung Cancer Patients
Lung cancer is the leading cause of deaths from cancers worldwide. Most lung cancers are characterized as non-small cell lung cancer and about 30% of patients progress to advanced stages when it…
Lung Cancer Rates Increasing Among Asian American Non-Smoking Women
Lung cancer is a rising concern among men and women all around the world. In the recent times, it has been found that lung cancer rates are dropping for every group except…
Gene Signature to Help Patients with NSCLC
Lung cancer is the leading cause of cancer mortality in the United States and all across the world. Non-small cell lung cancer (NSCLC) accounts for about 80 to 85% of all lung…
Novel Approach Using Patients Own Cells As Trojan Horse To Combat Lung Cancer
Lung cancer is by far the deadliest form of cancers all around the world. Although there are various treatments available like chemotherapy, surgery, radiation therapy etc., but still lung cancer is responsible…
Understanding The Impact Of Mobocertinib Withdrawal On Lung Cancer
Mobocertinib is used to treat a specific type of lung cancer known as EGFR+ lung cancer. This is a non-smoking related form of lung cancer caused by specific gene mutations. Mobocertinib was…
Study Finds How Lung Cancer Transform into Another
Lung Cancer is one of the major causes behind death of many patients all around the world. Continuous research work and studies are being carried on to help patients in successful recovery…
Targeted Therapy Better than Immunotherapy in Some Patients with NSCLC
Non-small cell lung cancer continues to remain one of the main reasons behind cancer related deaths all across the world. Continuous studies and research works are going on that could help in…
SABR For Inoperable Early Stage NSCLC
Stereotactic Ablative Radiotherapy (SABR) is an external beam treatment modality that delivers high precision large doses of radiation. In simple words, it is a way of giving Radiotherapy to precisely target cancer…
Combination Of Radiation And Immunotherapy For Advanced Non-Small Cell Lung Cancer
According to the new study by researchers from the UCLA Health Jonsson Comprehensive Cancer Center, using high doses of radiation with an ablative radiotherapy technique is effective for treatment with locally advanced…